Hemp, THC and CBD laws in Rhode Island
We track 2 Rhode Island rules on hemp, delta-8, THCA and CBD products; all are bans.
Check a specific item for Rhode IslandRhode Island
BannedDo not ship ingestible or inhalable hemp/CBD products (CBD oils, gummies, drinks, capsules, hemp flower, pre-rolls, vapes) to Rhode Island consumers: they may be sold only by a Rhode Island Cannabis Control Commission-licensed CBD retailer, only to buyers 21+, after ID check.
R.I. Gen. Laws § 2-26-5(b) · effective Jun 29, 2025 · draft
Exact text
(b) All growers, handlers, licensed CBD distributors, and licensed CBD retailers must have a hemp license issued by the commission. All production, distribution, and retail sale of hemp-derived consumable CBD products must be consistent with any applicable state or local food processing and safety regulations, and the applicant shall be responsible to ensure its compliance with the regulations and any applicable food safety licensing requirements, including, but not limited to, those promulgated by
BannedDo not ship intoxicating hemp products to Rhode Island: consumable hemp products are capped at 1 mg total THC per serving, 5 mg per package and 0.3% total THC (THCA and all isomers counted), and converted/synthetic cannabinoids (delta-8 etc.) are prohibited.
560-RICR-10-20-1 (Rhode Island Industrial Hemp Program, Cannabis Control Commission) §§ 1.5(A)(2), (H), (P), (LL); conversion prohibition; 1.11(G), (H), (K) · effective Dec 8, 2025 · draft
Exact text
1.5 Definitions A. "Acceptable Hemp THC level" or ".n% THC" as used throughout this Part means: 1. Prior to Harvest: The level of THC in a given hemp sample reported by the laboratory conducting the testing in accordance with Licensing Analytical Laboratories for Sampling and Testing Cannabis 216-RICR-60-05-6.21, which applies the measurement of uncertainty, reported in conjunction with a confidence level of at least 95% in accordance with the USDA's Testing Guidelines for Identifying Delta-9 Tetrahydrocannibinol (THC) in Hemp, to the total reported delta-9 tetrahydrocannabinol content concentration and which complies with § 1.5(R) of this Part; and 2. Post Harvest: The level of total THC, including THCa, all isomers and derivatives thereof in a given hemp-derived consumable product sample with results reported by an approved testing facility shall not exceed, unless otherwise permitted by the Commission: 1 mg of total THC per serving, 5 mg of total THC per package, or .3% total THC on a dry weight basis pursuant to the applicable product type. ... H. “Consumable” and any of its grammatical derivatives means intended for ingestion by inhalation or oral intake by a human or animal. ... P. “Hemp-derived consumable CBD product” means any product meant for ingestion by a human or animal, including, but not limited to, concentrates, extracts, and cannabis-infused foods and products, which are certified pursuant to § 1.5(E) of this Part and may contain cannabidiol derived from a hemp plant as defined in R.I. Gen. Laws § 2-26-3, which shall only be sold to persons age twenty-one (21) or older, which shall not include products derived from exempt cannabis plant material as defined in 21 C.F.R. § 1308.35. ... LL. "THC" as used in this Part means THC as defined in R.I. Gen. Laws § 2-26-3(13) and includes delta 9-tetrahydrocannabinol, the principal psychoactive constituent of cannabis, tetrahydrocannabinol acid and the natural or synthetic equivalents of the substances contained in the plant, or in the resinous extractives of, cannabis sativa L., or any synthetic substances, compounds, salts, or derivatives of the plant or chemicals and their isomers. ... I. Any conversion of cannabidiol or any other cannabinoid to delta9-tetrahydrocannabinol, any derivative form of THC, or any other cannabinoid by any licensee and/or the subsequent sale of such synthetic cannabinoids in the Program is strictly prohibited unless an approved variance for such a process and/or sale is approved and issued by the Commission. ... G. Allowable Product Types 1. Licensees shall be permitted to produce, manufacture distribute and/or dispense at retail to a consumer: a. Raw hemp flower which may include raw hemp in pre-roll form; b. Infused Pre-Packaged Products intended to be consumed orally ; c. Infused Unpackaged Products intended to be consumed orally; and d. Concentrates intended for inhalation. e. Any other product type designated as allowable for sale by the Commission. H. Product Prohibitions 1. No hemp-derived consumable CBD product intended for retail sale shall: a. Be in the shape of a human, animal, fruit, cartoon character, or any other shape that is especially attractive to children as determined by the Commission; b. Be in the shape of a cannabis plant or leaf; c. Be combined with alcohol, tobacco, nicotine, and/or any synthetic cannabinoids; d. Cause a reasonable consumer confusion as to whether the product is a trademarked product; e. Violate any state or federal trademark law or regulation; and/or f. Contain more than the Acceptable Hemp THC level, as applicable based on product type. I. Packaging and Labeling Requirements for allowable Hemp-Derived Consumable CBD Products available for sale to a consumer at retail. ... K. Retail Sales 1. A retail licensee shall only allow persons twenty-one (21) years of age or older to purchase hemp-derived consumable CBD products, in accordance with R.I. Gen. Laws § 2-26-3(9). 2. Pursuant to the Commission's authority under R.I. Gen. Laws § 2-26-6(b), a retail licensee must verify that every purchaser of a hemp-derived consumable CBD product is compliant with § 1.11(K)(1) of this Part by a review of the intended purchaser’s government-issued identification. ... - effective from 12/08/2025
Federal
These apply in every state.
BannedFrom Dec. 11, 2026 (unless Congress extends the delay again), federal law no longer treats as hemp any consumer product with more than 0.4 mg total THC (incl. THCA) per container or any synthesized/converted cannabinoid, so delta-8/THCA/hemp-THC edibles and hemp flower become federally illegal marijuana everywhere in the US.
Pub. L. 119-37, div. B, sec. 781 (139 Stat. 558), amending 7 U.S.C. 1639o · effective Dec 11, 2026 · draft
Exact text
Sec. 781. <<NOTE: Effective date. 7 USC 1639o note.>> Effective 365 days after the enactment of this Act, Section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o) is amended-- ... ``(A) In general.--The term `hemp' means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total tetrahydrocannabinols concentration (including tetrahydrocannabinolic acid) of not more than 0.3 percent on a dry weight basis. ... ``(C) Exclusions.--Such term does not include-- ... ``(iii) any intermediate hemp-derived cannabinoid products which are marketed or sold as a final product or directly to an end consumer for personal or household use; or ``(iv) any final hemp-derived cannabinoid products containing-- ``(I) cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; ``(II) cannabinoids that-- ``(aa) are capable of being naturally produced by a Cannabis sativa L. plant; and ``(bb) were synthesized or manufactured outside the plant; or ``(III) greater than 0.4 milligrams combined total per container of-- ``(aa) total tetrahydrocannabinols (including tetrahydrocannabinolic acid); and ``(bb) any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals as a tetrahydrocannabinol (as determined by the Secretary of Health and Human Services). ... ``(C) The term `container' means the innermost wrapping, packaging, or vessel in direct contact with a final hemp-derived cannabinoid product in which the final hemp-derived cannabinoid product is enclosed for retail sale to consumers, such as a jar, bottle, bag, box, packet, can, carton, or cartridge.
BannedFrom Nov. 12, 2026, hemp products containing cannabinoids that the cannabis plant cannot naturally produce (e.g. THC-O acetate, HHC and other lab-made cannabinoids) are excluded from the federal hemp definition and are Schedule I nationwide.
Pub. L. 119-103, div. B, sec. 2019 (140 Stat. 1003) · effective Nov 12, 2026 · draft
Exact text
SEC. 2019. <<NOTE: Applicability.>> SECTION 781 EXTENSION. Until December 11, 2026, the amendments made by section 781 of division B of Public Law 119-37 (7 U.S.C. 1639o note) shall only apply with respect to products described in paragraphs (1)(C)(ii)(I) and (1)(C)(iv)(I) of section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o) (as amended by such section 781).
BannedDEA treats HHC and any THC made by chemically converting hemp CBD (most delta-8/delta-10, THC-O, HHC products) as Schedule I synthetic THC; don't ship them anywhere in the US.
21 CFR 1308.11(d) - Specific listing for hexahydrocannabinol (DEA final rule, 91 FR 23913, May 4, 2026) · effective May 4, 2026 · draft
Exact text
Hexahydrocannabinol is currently controlled in schedule I as a tetrahydrocannabinol. ... Thus, only tetrahydrocannabinols in or derived from the cannabis plant--not synthetic tetrahydrocannabinols--are excluded from control as ``tetrahydrocannabinols in hemp.'' To clarify further, tetrahydrocannabinols produced through chemical conversion, even when hemp derived are considered synthetically produced for purposes of the CSA, do not qualify as ``tetrahydrocannabinols in hemp'' under the AIA.
BannedDon't mail THCA flower or synthetic/converted-cannabinoid products by USPS: Pub 52 allows hemp only if it meets the federal hemp definition and every applicable law, and keeps tracking any 'successor' definition.
Exact text
453.37 Hemp-Based Products For purposes of this section, "hemp" refers to the definition provided under federal law, including Section 10113 of the Agricultural Improvement Act of 2018, Pub. L.115-334 (7 U.S.C. § 1639o), or any successor provision. Hemp and hemp-based products, including cannabidiol (CBD) with the tetrahydrocannabinol (THC) concentration of such hemp (or its derivatives) not exceeding a 0.3 percent limit are permitted to be mailed domestically only when the mailer: Complies with all applicable federal, state, and local laws, including U.S. Department of Agriculture approved plans for hemp production, processing, distribution, and sales (7 CFR Part 990). Retains records establishing compliance with such laws and plans, including laboratory test results, licenses, or compliance reports, for no less than 3 years after the date of mailing. Shipments of hemp and hemp-based products, including CBD, are prohibited in international mail, including items for delivery to overseas Army Post Office, Fleet Post Office, and Diplomatic Post Office addresses (APO/FPO/DPO).
Permit neededUPS carries hemp and CBD products only for shippers with a UPS contract for them, and never carries vape products; don't ship hemp/CBD by UPS without that agreement.
Exact text
Marijuana, including marijuana intended for medical use and Cannabidoil ("CBD") derived from Marijuana
...
Vape products within, to or from the U.S
...
Certain items we list as prohibited will be accepted by UPS on a contractual basis for shippers with regular volume and the ability to comply with all applicable laws and regulations. The items we can carry under certain criteria are:
...
Hemp and CBDBannedFDA's position is that CBD or THC foods, drinks and dietary supplements cannot lawfully be shipped across state lines, so interstate online sales of CBD/THC gummies, beverages or supplements are federally prohibited.
Exact text
9. Can THC or CBD products be sold as dietary supplements? A. No. Based on available evidence, FDA has concluded that THC and CBD products are excluded from the dietary supplement definition under section 201(ff)(3)(B) of the FD&C Act [21 U.S.C. § 321(ff)(3)(B)]. ... 10. Is it legal, in interstate commerce, to sell a food (including any animal food or feed) to which THC or CBD has been added? A. No. Under section 301(ll) of the FD&C Act [21 U.S.C. § 331(ll)], it is prohibited to introduce or deliver for introduction into interstate commerce any food (including any animal food or feed) to which has been added a substance which is an active ingredient in a drug product that has been approved under section 505 of the FD&C Act [21 U.S.C. § 355], or a drug for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public.